Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,617.10 -329.83 (-0.85%) Hang Seng
19,214.74 -5.88 (-0.03%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,824.08 -1,340.66 (-1.88%) CMC Crypto 200
1,471.16 -55.26 (-3.62%)
Cellectar Biosciences, Inc. (CLRB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 116.51M |
| Enterprise value | 94.10M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 12.82 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 112.42% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 4.4500 |
| 52-week low 3 | 1.4800 |
| 50-day moving average 3 | 3.4394 |
| 200-day moving average 3 | 2.8925 |
Share statistics
| Avg vol (3-month) 3 | 959.88k |
| Avg vol (10-day) 3 | 609.73k |
| Shares outstanding 5 | 35.85M |
| Implied shares outstanding 6 | 35.85M |
| Float 8 | 26.9M |
| % held by insiders 1 | 3.20% |
| % held by institutions 1 | 23.62% |
| Shares short (30 Apr 2024) 4 | 2.55M |
| Short ratio (30 Apr 2024) 4 | 2.83 |
| Short % of float (30 Apr 2024) 4 | 8.06% |
| Short % of shares outstanding (30 Apr 2024) 4 | 7.10% |
| Shares short (prior month 28 Mar 2024) 4 | 2.53M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 17 Jul 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 22 Jul 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -91.47% |
| Return on equity (ttm) | -304.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -42.02M |
| Net income avi to common (ttm) | -50.98M |
| Diluted EPS (ttm) | -3.0900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 40.03M |
| Total cash per share (mrq) | 1.12 |
| Total debt (mrq) | 548.34k |
| Total debt/equity (mrq) | 2.10% |
| Current ratio (mrq) | 2.54 |
| Book value per share (mrq) | 0.27 |
Cash flow statement
| Operating cash flow (ttm) | -38.55M |
| Levered free cash flow (ttm) | -15.53M |
© 2024 Yahoo. All rights reserved.